Train Babcock Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Train Babcock Advisors's BMY Position: Q4 2017 in Review
Train Babcock Advisors reduced its Bristol-Myers Squibb (BMY) stake by 22% in Q4 2017, selling an estimated $63.4K and leaving 3,502 shares worth $215K. The position accounts for 0.09% of the portfolio, ranked #91.
Train Babcock Advisors first reported a position in BMY in Q2 2013 and has held it in 19 quarters since. The position peaked at $710K in Q4 2013. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.
- Train Babcock Advisors held 3,502 shares of Bristol-Myers Squibb worth $215K as of Q4 2017.
- Train Babcock Advisors sold 1,014 Bristol-Myers Squibb shares in Q4 2017, an estimated $63.4K.
- Bristol-Myers Squibb made up 0.09% of Train Babcock Advisors's portfolio in Q4 2017, its #91 holding.
- Train Babcock Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 19 quarters since.
- Train Babcock Advisors's Bristol-Myers Squibb position peaked at $710K in Q4 2013.
- 1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.
Based on Train Babcock Advisors's 13F filing for Q4 2017, filed 10 Jan 2018.